glp 1 and dpp4 GLP-1-based therapies for type 2 diabetes: from single, dual triple agonists to endogenous GLP-1 production and L-cell differentiation | Diabetology & Metabolic Syndrome dpp-4_inhibitors [TUSOM | Pharmwiki]
Pay in 4 interest-free payments of $7.47 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
![glp 1 and dpp4 GLP-1-based therapies for type 2 diabetes: from single, dual triple agonists to endogenous GLP-1 production and L-cell differentiation | Diabetology & Metabolic Syndrome dpp-4_inhibitors [TUSOM | Pharmwiki]](https://tmedweb.tulane.edu/pharmwiki/lib/exe/fetch.php/dpp4.png?w=600&tok=f9724b)
![glp 1 and dpp4 GLP-1-based therapies for type 2 diabetes: from single, dual triple agonists to endogenous GLP-1 production and L-cell differentiation | Diabetology & Metabolic Syndrome dpp-4_inhibitors [TUSOM | Pharmwiki]](https://figures.semanticscholar.org/10b9e57d49ea4628324390cde4d3e80d0a5562fd/2-Figure1-1.png)
![glp 1 and dpp4 GLP-1-based therapies for type 2 diabetes: from single, dual triple agonists to endogenous GLP-1 production and L-cell differentiation | Diabetology & Metabolic Syndrome dpp-4_inhibitors [TUSOM | Pharmwiki]](https://synapse-static.patsnap.com/strapi-static/image_88cfe26924.png)
![glp 1 and dpp4 GLP-1-based therapies for type 2 diabetes: from single, dual triple agonists to endogenous GLP-1 production and L-cell differentiation | Diabetology & Metabolic Syndrome dpp-4_inhibitors [TUSOM | Pharmwiki]](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs12933-017-0648-x/MediaObjects/12933_2017_648_Fig1_HTML.gif)








:max_bytes(150000):strip_icc():focal(749x0:751x2)/oatzempic-040124-5-c01290c2c2d8468c9fcfa1195527e52a.jpg)










